January 7, 2017

No Image

Students Zap Their Brains For a Boost, For Better Or Worse

Matt Herich uses a tDCS device that was made by another student he met on Reddit. Four 9-volt batteries and sticky self-adhesive electrodes are connected by a circuit board that sends a constant small current to the user’s brain. Courtesy of Matt Herich hide caption

toggle caption

Courtesy of Matt Herich

Last October, Matt Herich was listening to the news while he drove door to door delivering pizzas. A story came on the radio about a technology that sends an electric current through your brain to possibly make you better at some things — moving, remembering, learning. He was fascinated.

The neurotechnology is called transcranial direct current stimulation, or tDCS for short. At its simplest, the method involves a device that uses little more than a 9-volt battery and some electrodes to send a low-intensity electrical current to a targeted area of the brain, typically via a headset.

More than a 1,000 studies have been published in peer-reviewed journals over the last decade suggesting benefits of the technique — maybe regulating mood, possibly improving language skills — but its effects, good or bad, are far from clear.

Although researchers see possibilities for tDCS in treating diseases and boosting performance, it’s still an exploratory technology, says Mark George, editor-in-chief of Brain Stimulation, a leading journal on neuromodulation. And leading experts have warned against at-home use of such devices.

“If we can figure out safe long-term applications, it’s so inexpensive we might be able to use it to boost tons of things,” says George, a professor at the Medical University of South Carolina. “But I have to underline might — we don’t know yet.”

A user wears a tDCS device sold by an online retailer, Caputron. Courtesy of Robin Azzam hide caption

toggle caption

Courtesy of Robin Azzam

When Herich finished his shift delivering pizzas, he raced home and began googling. He found a thriving community on Reddit and other online forums dedicated to discussing ways to self-administer tDCS.

After reading some scientific studies on neurostimulation, Herich decided to give it a try. He eventually got his hands on a rudimentary tDCS device made by a student at Northern Arizona University.

Article continues after sponsorship

“I did my research before I put the device on my head,” Herich says. “So it was a mix between me being confident it would be safe and me taking a leap of faith.”

The circuit board on Herich’s tDCS device regulates a constant current of 2 milliamps sent to the user’s brain from four 9-volt batteries. Courtesy of Matt Herich hide caption

toggle caption

Courtesy of Matt Herich

In his opinion, the leap of faith paid off. Herich takes online courses on machine learning, and he says that one 20-minute session of tDCS puts him in a state of intense focus that increases his productivity and helps him learn abstract math much faster than before.

Herich is not alone — beyond the DIY neurostimulation community, companies are cashing in on the phenomenon, offering brain stimulation kits and ready-to-wear headsets, like Thync and Halo. While the simplest devices can be made with items found in a hardware store, the best-selling versions like ActivaDose or the Foc.us can cost more than $300.

And sales of the devices spike at fairly regular times, says Robin Azzam, CEO of a leading tDCS retailer Caputron: around college midterms and finals. Caputron also helps point customers to academic studies about tDCS. And Azzam says articles on cognitive enhancement are in particularly high demand during exam times.

[embedded content]

Researchers show how tDCS is administered in clinical settings to explore treatments for chronic pain.

YouTube

George says he’s also heard students are using tDCS to study for exams, but he doesn’t recommend it: There isn’t enough data to back up claims that it is effective or safe.

He says an updated article will be published soon detailing the experts’ concerns about liberal use of tDCS by the DIY community. The main worries include the risks of mistakes in administration by amateurs and the uncertainty of long-term harmful effects of the technique.

Besides, George says, at-home users that attempt to study with the device may actually be doing themselves a disservice.

“When we learn something, we’re more likely to remember it in the same environment as when we learned it,” he says. “So if you study with one of these devices on and then you take your test without the device, you’ve violated that rule. You may be very good with it on, but unless they allow you to do that in the exam you’re actually hurting yourself.”

Plus, the safety of devices can vary — given that most tDCS devices aren’t marketed with specific medical claims, they are not reviewed by the Food and Drug Administration.

“A lot of the people that buy these think that they’re safe because a company is allowed to sell them,” says Vince Clark, director of the Psychology Clinical Neuroscience Center at the University of New Mexico. “What they don’t know is that a lot of those devices are never evaluated by the FDA. They go to market without safety studies that everybody expects must have happened. They haven’t.”

But like Herich, many users read the literature that supports and condemns tDCS use outside of clinical settings and choose to move forward anyway. And according to one academic review of the do-it-yourself brain stimulation community, most DIYers do draw heavily on existing scientific knowledge, circulate academic journal articles and adopt the standard electrode placement used by scientists.

“I do understand the risks,” Herich says. “I know … the nature of what it is that I’m doing, connecting a 9-volt to the forehead.” He acknowledges that to many people it may sound crazy. “I don’t know,” he says, “I think I just accept that risk.”

Let’s block ads! (Why?)


No Image

What To Watch For In Sports This Year

In this week’s sports roundup: The start of NFL playoffs, the fate of running back Joe Mixon, who was caught on video punching a woman in 2014, and a 105-year-old Frenchman still on his bike.

SCOTT SIMON, HOST:

And it’s time for sports.

(SOUNDBITE OF MUSIC)

SIMON: It’s less than a month until the Super Bowl. And the NFL playoffs begin today. NPR’s Tom Goldman joins us now for the first time in 2017. Good morning, Tom.

TOM GOLDMAN, BYLINE: Well, good morning. And Happy New Year.

SIMON: And Happy New Year to you, my friend. Now, I know you’re deeply opposed to making predictions, which just makes you smart compared to the rest of us.

GOLDMAN: (Laughter).

SIMON: But what will you be watching for in these playoffs?

GOLDMAN: Well, OK. Number one – can a team lose its star quarterback to injury and still win with a third-string rookie making his first NFL start in a playoff game? That would be Oakland, which lost Derek Carr, its starting quarterback, to a broken leg – then the second-stringer to a shoulder injury. Next man up is Connor Cook, starting against Houston in today’s first game. Now, history says it’ll be a tough day for the rookie. But his coach liked the way Cook looked when he came in last week and threw 21 passes in a loss to Denver. But, of course, that wasn’t a playoff game.

And then tomorrow, when two hot teams meet in frigid temperatures, who stays hot? That would be the New York Giants against the Green Bay Packers in Green Bay, where weather is supposed to be around 13 degrees at game time – makes me cold just to say that. The Packers have won six straight with the best quarterback in the NFL right now, Aaron Rodgers, leading the way. The Giants are playing well. We’ve seen this before, Scott, with the Giants. In 2007, 2011, they caught fire late. They beat the Patriots in the Super Bowl both times. But I’m not sure they can…

SIMON: And some guy just catches a pass next to his helmet – is what happens – the Giants, yeah.

GOLDMAN: That’s all it takes, yeah. But I’m not sure they can do that again this time unless their offense plays better and unless they find a wide receiver who can catch a ball with his head.

SIMON: (Laughter) Yeah. That’s quite a – they work on that in training camp now.

GOLDMAN: Yeah.

SIMON: Joe Mixon of the Oklahoma Sooners wants to go pro. Videos made public – that’s utterly ugly to watch. Is it going to make it difficult for him to go pro?

GOLDMAN: Well, you know, we won’t know that until late April when the NFL draft happens. Mixon is a very good running back. But in 2014, he was suspended the entire freshman season after an argument at an Oklahoma restaurant ended with him punching a woman in the head. And that resulted in several fractures in her face. At the time, Mixon was charged with a misdemeanor and ordered to do community service and counseling.

But as you mentioned, a surveillance video showing the incident didn’t emerge until last month. And when it did, it created a national outcry. Mixon publicly apologized. And his head coach was criticized for saying if the incident happened now with the heightened awareness of violence against women, Mixon would’ve been kicked off the team.

SIMON: Yeah. I can’t let the week go by without noting that Robert Marchand – I believe that’s how you would pronounce his name…

GOLDMAN: Wait.

SIMON: …Set a new record for cycling. Oh, we use it. I’m sorry. He cycled 92 laps around a velodrome near Paris in an hour, set a new world record. He is 105 and says, I’m now waiting for arrival, which, Tom, I think, is a clear taunt at both of us. Don’t you?

GOLDMAN: It’s a clear taunt, obviously. And are we up to it, Scott? He’s got the heart to back it up, though. It’s apparently a very big, strong heart that beats slowly. His coach says Marchand has the heart of a 60-year-old.

SIMON: (Laughter).

GOLDMAN: So 60 must be the new 40 when it comes to healthy hearts. I don’t know. But yeah, 92 laps – that translates to 14 miles in one hour. That’s quite impressive.

SIMON: And he didn’t take up cycling until he was 68. Can you imagine that?

GOLDMAN: Yeah. He wanted to do something in his youth.

SIMON: (Laughter).

GOLDMAN: He took it up with a vengeance, though. He bikes between six and 12 miles a day on a stationary bike. So no excuses. It’s 2017. Let’s get out there.

SIMON: All right. NPR’s Tom Goldman, thanks so much.

GOLDMAN: Thank you.

Copyright © 2017 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Let’s block ads! (Why?)


No Image

They Never Told Her That Girls Could Become Scientists

Mireille Kamariza, a graduate student in Stanford, is trying to develop a faster test to diagnose TB. Fred Tomlin/Courtesy of Mireille Kamariza hide caption

toggle caption

Fred Tomlin/Courtesy of Mireille Kamariza

By many standards, Mireille Kamariza is at the top of the world.

She’s a graduate student at one of the world’s top universities, working on her Ph.D. with one of the world’s top chemists. And she’s tackling a tough problem — tuberculosis — that sickens nearly 10 million people a year.

Earlier this year, 27-year-old Kamariza and her adviser unveiled a potential breakthrough in fighting TB: a way to detect the culprit bacteria faster and more accurately.

But for Kamariza, the fight against TB is not just about scientific progress and prestige. It’s personal.

Kamariza grew up in the small African country of Burundi, where many around her were stricken with TB. A close relative lived with the disease for years — and eventually died from it. It was common for people in her town to get sick with TB and “wait to see if you’d die — and if you survived, you’d just kind of live with it.”

A World Health Organization report released in October states that an estimated 10.4 million people were infected with TB in 2015, up from previous years — and 1.8 million died from the disease.

Article continues after sponsorship

TB is still a stigmatized disease in Burundi, so Kamariza doesn’t want to be specific about her relative’s identity. But, she says, he most likely didn’t get treated “because he didn’t know you could be treated, and even if he did know, [treatment] was far from where he was — and expensive.”

Kamariza’s journey hasn’t been easy. In Burundi, it’s rare for girls to attend college — not to mention work with world-class scientists.

“Science was something that Europeans and Americans did,” she says. “It was for other people — not for me.” When she was in high school, she didn’t have a clue about science careers. Neither did her parents.

“I never dreamed [Kamariza] would become a scientist because it is a career path that is unknown in Burundi,” says Denise Sinankwa, Kamariza’s mother.

Sinankwa had her hands full when Kamariza was young. She and her husband were raising four kids during a bloody civil war. Nearly 300,000 civilians were killed. The family moved a lot, and Sinankwa often worked multiple jobs to feed the family.

But Sinankwa still pushed Kamariza to do well in school. She wanted her daughter to land a good-paying job and be able to support herself.

Kamariza considers herself lucky. She attended a government-managed Catholic school, where “things were more rigorous” than other public schools. The “nuns’ school” instilled a mindset most of her peers lacked because generally girls “were raised to be a wife,” she says.

Kamariza wanted to pursue studies in the U.S., where her second-oldest brother had already landed. So, when she was 17, Kamariza packed up her belongings and traveled with her third brother half way around the world. She went to San Diego in the fall of 2006 and moved into a tiny studio apartment with her brothers. The four worked various jobs at grocery stores, restaurants, retail shops — “whatever we could get to pay the bills,” Kamariza says. Their earnings also paid for classes at a junior college.

Then Kamariza’s hard work started to pay off.

At San Diego Mesa College, she found a life-changing mentor. Her chemistry teacher, Saloua Saidane, was a fellow French-speaking African. Born to illiterate parents in Tunisia, Saidane was one of 12 children and knew what it was like to be a poor immigrant kid pouring herself into school as the only way to a better future.

“Kamariza was serene yet determined,” Saidane says. “She worked hard. She saw the opportunity to have a good life, a life different from what she left behind.”

Saidane started Kamariza’s journey into science. “She really pushed me and kept motivating me and telling me I should aim high. Whatever she told me, I did,” Kamariza says.

After quitting her job at Safeway to focus on school, Kamariza got into the University of California, San Diego, and began undergraduate studies. Through a National Institutes of Health diversity scholarship, Kamariza spent summers doing biology research. In 2012, she joined Carolyn Bertozzi‘s lab — then at the University of California, Berkeley, now at Stanford University — as a graduate student.

Kamariza wanted to focus on infectious disease. So she started brainstorming with another graduate student to figure out a quicker, better way to diagnose TB.

They eventually came up with a new test that recognizes a sugar, called trehalose, that is uniquely found in TB bacteria. In the presence of a special substance, TB bacteria cells glow green, making the microbes easy to spot on microscope slides of an infected person’s mucus or saliva.

Current TB tests are laborious and not very sensitive — some infections are missed. TB cultures are more reliable but take six weeks to produce a result. Kamariza — and other researchers elsewhere — are creating methods that could make TB diagnoses simpler and more accurate.

Kamariza’s method looked promising this year when she and her colleagues tested it on a small batch of samples from patients in South Africa. But the tools are still in the developmental phase. Larger, more rigorous studies are needed for the method to be considered for use in clinics.

Though unfinished, the research drew heavy crowds when Kamariza presented her data on a poster at a TB conference in September in Paris. Considering her improbable journey — from a child witnessing the tragedy of this disease to a young researcher contributing toward its eradication — “the whole experience is surreal,” Kamariza says.

“A lot of hard work, a bit of luck, perseverance and relentless support from friends and family are what got me here,” says Kamariza, She hopes her experience can “encourage others like me to pursue their passions, no matter the obstacles.”

Let’s block ads! (Why?)